Noninvasive Determination of Fetal Rh Blood Group, D Antigen Status by Cell-Free DNA Analysis in Maternal Plasma: Experience in a Brazilian Population

ABSTRACT

We evaluated the diagnostic accuracy of Rh blood group, D antigen (RHD) fetal genotyping, using real-time polymerase chain reaction in maternal blood samples, in a racially mixed population. We performed a prospective study conducted between January 2006 and December 2007, analyzing fetal RHD genotype in the plasma of 102 D− pregnant women by real-time polymerase chain reaction, targeting exons 7 and 10 of the RHD gene. Genotype results were compared with cord blood phenotype obtained after delivery or before the first intrauterine transfusion when necessary. Most of the participants (75.5%) were under 28 weeks of pregnancy, and 87.5% had at least one relative of black ancestry. By combining amplification of two exons, the accuracy of genotyping was 98%, sensitivity was 100%, and specificity was 92%. The positive likelihood ratio was 12.5, and the negative likelihood ratio was 0. The two false-positive cases were confirmed to be pseudogene RHD by real-time polymerase chain reaction. There were no differences between the patients with positive or negative Coombs test (p = 0.479). Determination of fetal RHD status in maternal peripheral blood was highly sensitive in this racially mixed population and was not influenced by the presence of antierythrocyte antibodies.

Prenatal diagnosis - cell-free DNA - fetal RHD status - real-time polymerase chain

REFERENCES

• 1 Singleton B K, Green C A, Avent N D et al.. The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in Africans with the Rh D-negative blood group phenotype.  Blood. 2000;  95 12-18
• 2 Clausen F B, Krog G R, Rieneck K et al.. Reliable test for prenatal prediction of fetal RhD type using maternal plasma from RhD negative women.  Prenat Diagn. 2005;  25 1040-1044
• 3 Costa J M, Giovangrandi Y, Ernault P et al.. Fetal RHD genotyping in maternal serum during the first trimester of pregnancy.  Br J Haematol. 2002;  119 255-260
• 4 Finning K M, Martin P G, Soothill P W, Avent N D. Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service.  Transfusion. 2002;  42 1079-1085
• 5 Gautier E, Benachi A, Giovangrandi Y et al.. Fetal RhD genotyping by maternal serum analysis: a two-year experience.  Am J Obstet Gynecol. 2005;  192 666-669
• 6 Hromadnikova I, Vechetova L, Vesela K et al.. Non-invasive fetal RHD exon 7 and exon 10 genotyping using real-time PCR testing of fetal DNA in maternal plasma.  Fetal Diagn Ther. 2005;  20 275-280
• 7 Minon J M, Gerard C, Senterre J M, Schaaps J P, Foidart J M. Routine fetal RHD genotyping with maternal plasma: a four-year experience in Belgium.  Transfusion. 2008;  48 373-381
• 8 Turner M J, Martin C M, O'Leary J J. Detection of fetal Rhesus D gene in whole blood of women booking for routine antenatal care.  Eur J Obstet Gynecol Reprod Biol. 2003;  108 29-32
• 9 Martinhago C D, de Oliveira R M, Tomitão Canas MdoC et al.. Accuracy of fetal gender determination in maternal plasma at 5 and 6 weeks of pregnancy.  Prenat Diagn. 2006;  26 1219-1223
• 10 Grootkerk-Tax M G, Maaskant-van Wijk P A, van Drunen J, van der Schoot C E. The highly variable RH locus in nonwhite persons hampers RHD zygosity determination but yields more insight into RH-related evolutionary events.  Transfusion. 2005;  45 327-337
• 11 Rodrigues A, Rios M, Pellegrino Jr J, Costa F F, Castilho L. Presence of the RHD pseudogene and the hybrid RHD-CE-D(s) gene in Brazilians with the D-negative phenotype.  Braz J Med Biol Res. 2002;  35 767-773
• 12 Bennett P R, Warwick R, Letsky E, Fisk N M. Determination of fetal RhD type by DNA amplification from fetal skin following massive fetomaternal haemorrhage and intrauterine fetal death.  Br J Obstet Gynaecol. 1994;  101 636-637
• 13 Kenny-Walsh E. Irish Hepatology Research Group . Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin.  N Engl J Med. 1999;  340 1228-1233